Return to Trial Database

HCRN-LUN21-530

MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer (MOZART)

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Publications

A phase II trial of monalizumab in combination with durvalumab (MEDI4736) plus platinum-based chemotherapy for first-line treatment of extensive stage small cell lung cancer (MOZART)

Trial Locations

All sites in which the trial HCRN-LUN21-530 being conducted in.

Barbara Ann Karmanos Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

University of Iowa Holden Comprehensive Cancer Center

University of Virginia Cancer Center